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Background Aims
Conclusion
Results
During HIV-1 infection, the integrity of the intestinal immune barrier is
disrupted due to a deep depletion of CD4+ T cells in the gut. The
translocation of microbial products from the gut lumen into the
bloodstream has been linked with systemic inflammation. Despite long-
term effective cART, CD4+ T cells in the lamina propria are incompletely
restored in most individuals.
Among the chemotactic axes involved in CD4+ T cell homing to the
gut, we focused on the CCR6-CCL20 axis as it governs Th17 cells
homing, a T cell subset exerting a major role in antimicrobial immunity.
We aimed to assess the factors regulating the expression of CCL20 by
the enterocytes, and notably the role of the cytokines produced by Treg
and Th17 cells.
Methods
Figure 3 : Microbial sensing induces expression of
CCL20 by the small intestine epithelial cells. (Pam3CSK4:
TLR1/2 agonist, HKLM: TLR2 agonist, LPS: TLR4 agonist, ST-FLA:
TLR5 agonist, FSL-1: TLR6/2 MDP: NOD2 agonist)
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Figure 4 : Th17 cytokines induce expression of the
CCL20 chemokine by the small intestine epithelial cells
in contrary to Treg cytokines.
Figure 5 : Ex vivo, Th17 cytokines induce
expression of CCL20 by the small intestine
epithelial cells in contrary to Treg
cytokines. (IEC : Intestinal Epithelial Cells)
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homing is altered in contrast
to Treg cells resulting in an
imbalanced Th17/Treg ratio
in the small intestinal
mucosa of treated HIV-1
infected individuals.
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Figure 1 : Impaired CCL20 production by the
enterocytes disrupts the homing of CD4+
CCR6+ T cells to small intestinal mucosa in
virologically suppressed HIV-1 infected
individuals.
Figure 6 : In vivo, an imbalanced Th17/Treg ratio
in the small intestine mucosa contributes to the
alteration of the gut homing of CD4+ CCR6+ T
cells in virologically suppressed HIV-1 infected
individuals. ( : HIV-1+, : HIV-1-)
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Small bowel biopsies were obtained by endoscopy in 20 HIV-1+ and 10
HIV-1- individuals. Intestinal lymphocytes phenotype was analyzed by
flow cytometry. CCL20 mRNA was quantified by qRT-PCR. The effect
of PRR ligands and cytokines on CCL20 expression was explored using
an ex-vivo system of human primary enterocytes. A coculture was done
between the enterocytes and Th17/Treg cells. The expression of
CCL20 by the enterocytes was evaluated by qRT-PCR and ELISA
